94 related articles for article (PubMed ID: 7502711)
1. Multiple molecular forms of pyridinolines cross-links excreted in human urine evaluated by chromatographic and immunoassay methods.
Kamel S; Brazier M; Neri V; Picard C; Samson L; Desmet G; Sebert JL
J Bone Miner Res; 1995 Sep; 10(9):1385-92. PubMed ID: 7502711
[TBL] [Abstract][Full Text] [Related]
2. Different responses of free and peptide-bound cross-links to vitamin D and calcium supplementation in elderly women with vitamin D insufficiency.
Kamel S; Brazier M; Rogez JC; Vincent O; Maamer M; Desmet G; Sebert JL
J Clin Endocrinol Metab; 1996 Oct; 81(10):3717-21. PubMed ID: 8855828
[TBL] [Abstract][Full Text] [Related]
3. [Urinary excretion of free and total deoxypyridinoline during secondary hyperparathyroidism in the elderly. Comparison of chromatographic (HPLC) and immunoenzymatic (Pyrilinks-D) methods].
Meddah B; Brazier M; Kamel S; Maamer M; Samson L; Desmet G; Sebert JL
Ann Biol Clin (Paris); 1996; 54(10-11):353-8. PubMed ID: 9092303
[TBL] [Abstract][Full Text] [Related]
4. Urinary excretion of pyridinolines crosslinks measured by immunoassay and HPLC techniques in normal subjects and in elderly patients with vitamin D deficiency.
Kamel S; Brazier M; Picard C; Boitte F; Samson L; Desmet G; Sebert JL
Bone Miner; 1994 Sep; 26(3):197-208. PubMed ID: 7819827
[TBL] [Abstract][Full Text] [Related]
5. Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption.
Robins SP; Woitge H; Hesley R; Ju J; Seyedin S; Seibel MJ
J Bone Miner Res; 1994 Oct; 9(10):1643-9. PubMed ID: 7817812
[TBL] [Abstract][Full Text] [Related]
6. Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion.
Garnero P; Gineyts E; Arbault P; Christiansen C; Delmas PD
J Bone Miner Res; 1995 Apr; 10(4):641-9. PubMed ID: 7610936
[TBL] [Abstract][Full Text] [Related]
7. [Reference values of assayable pyridinolines as markers of bone turn-over].
Zolezzi C; Lenzi L; Salizzoni MP; Pizzoferrato A
Minerva Med; 1995; 86(1-2):5-9. PubMed ID: 7753439
[TBL] [Abstract][Full Text] [Related]
8. Validation of a high-performance liquid chromatographic assay for lysylpyridinoline in urine: a potential biomarker of bone resorption.
Casserly UM; O'Rorke A; Power MJ; Fottrell PF
Anal Biochem; 1996 Nov; 242(2):255-60. PubMed ID: 8937570
[TBL] [Abstract][Full Text] [Related]
9. Pyridinoline cross-links as markers for primary and secondary bone tumors.
Behrens P; Bruns J; Ullrich KP; Açil Y; Gille J
Scand J Clin Lab Invest; 2003; 63(1):37-44. PubMed ID: 12729068
[TBL] [Abstract][Full Text] [Related]
10. Automated and manual assays for urinary crosslinks of collagen: which assay to use?
Seibel MJ; Woitge HW; Farahmand I; Oberwittler H; Ziegler R
Exp Clin Endocrinol Diabetes; 1998; 106(2):143-8. PubMed ID: 9628247
[TBL] [Abstract][Full Text] [Related]
11. Immunoassay for urinary pyridinoline: the new marker of bone resorption.
Seyedin SM; Kung VT; Daniloff YN; Hesley RP; Gomez B; Nielsen LA; Rosen HN; Zuk RF
J Bone Miner Res; 1993 May; 8(5):635-41. PubMed ID: 8511991
[TBL] [Abstract][Full Text] [Related]
12. Urinary excretion of collagen degradation markers by sows during postpartum uterine involution.
Belstra BA; Flowers WL; Croom WJ; Degroot J; See MT
Anim Reprod Sci; 2005 Jan; 85(1-2):131-45. PubMed ID: 15556316
[TBL] [Abstract][Full Text] [Related]
13. Urinary bone resorption markers (deoxypyridinoline and C-terminal telopeptide of type I collagen) in healthy persons, postmenopausal osteoporosis and patients with type I diabetes.
Fassbender WJ; Gödde M; Brandenburg VM; Usadel KH; Stumpf UC
Adv Med Sci; 2009; 54(1):1-6. PubMed ID: 19482729
[TBL] [Abstract][Full Text] [Related]
14. Urinary hydroxypyridinium crosslinks of collagen in population-based screening for overt vertebral osteoporosis: results of a pilot study.
Seibel MJ; Woitge H; Scheidt-Nave C; Leidig-Bruckner G; Duncan A; Nicol P; Ziegler R; Robins SP
J Bone Miner Res; 1994 Sep; 9(9):1433-40. PubMed ID: 7817828
[TBL] [Abstract][Full Text] [Related]
15. Mature enzymatic collagen cross-links, hydroxylysylpyridinoline and lysylpyridinoline, in the aging human vitreous.
Ponsioen TL; Deemter Mv; Bank RA; Snabel JM; Zijlstra GS; van der Worp RJ; Hooymans JM; Los LI
Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1041-6. PubMed ID: 18708624
[TBL] [Abstract][Full Text] [Related]
16. A comparison of methods for measuring serum and urinary markers of bone metabolism in cats.
DeLaurier A; Jackson B; Pfeiffer D; Ingham K; Horton MA; Price JS
Res Vet Sci; 2004 Aug; 77(1):29-39. PubMed ID: 15120950
[TBL] [Abstract][Full Text] [Related]
17. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study.
Garnero P; Hausherr E; Chapuy MC; Marcelli C; Grandjean H; Muller C; Cormier C; Bréart G; Meunier PJ; Delmas PD
J Bone Miner Res; 1996 Oct; 11(10):1531-8. PubMed ID: 8889854
[TBL] [Abstract][Full Text] [Related]
18. Changes with age in the urinary excretion of lysyl- and hydroxylysylpyridinoline, two new markers of bone collagen turnover.
Beardsworth LJ; Eyre DR; Dickson IR
J Bone Miner Res; 1990 Jul; 5(7):671-6. PubMed ID: 2118710
[TBL] [Abstract][Full Text] [Related]
19. Concentration of collagen cross-links in human dentin bears no relation to the individual age.
Açil Y; Springer IN; Prasse JG; Hedderich J; Jepsen S
Int J Legal Med; 2002 Dec; 116(6):340-3. PubMed ID: 12461641
[TBL] [Abstract][Full Text] [Related]
20. Comparison of biochemical markers of bone turnover in Paget disease treated with pamidronate and a proposed model for the relationships between measurements of the different forms of pyridinoline cross-links.
Randall AG; Kent GN; Garcia-Webb P; Bhagat CI; Pearce DJ; Gutteridge DH; Prince RL; Stewart G; Stuckey B; Will RK; Retallack RW; Price RI; Ward L
J Bone Miner Res; 1996 Aug; 11(8):1176-84. PubMed ID: 8854254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
